Cipla Q1 net profit rises 25% to Rs 709.92 crore on account of robust sales

By: |
August 05, 2021 9:34 PM

Shares of Cipla closed at Rs 945.20 per scrip on BSE, up 0.60 percent from its previous close.

Cipla Q1 profit, cipla resultsThe company had posted a net profit of Rs 566.04 crore in the corresponding period of the previous fiscal, Cipla said in a filing to BSE

Drug firm Cipla on Thursday reported a 25.41 per cent increase in its consolidated net profit to Rs 709.92 crore for the quarter ended June 30, 2021, on account of robust sales. The company had posted a net profit of Rs 566.04 crore in the corresponding period of the previous fiscal, Cipla said in a filing to BSE.

Consolidated total revenue from operations for the quarter under consideration stood at Rs 5,504.35 crore. It was Rs 4,346.16 crore for the same period a year ago, it added.

“I am pleased to see the robust demand led traction in core therapies across our branded markets and continued cost control leading to 27 percent revenue growth and 24.5 percent EBITDA (earnings before interest, taxes, depreciation, and amortization) margin for the quarter,” Cipla Managing Director and Global Chief Executive Officer Umang Vohra said.

Shares of Cipla closed at Rs 945.20 per scrip on BSE, up 0.60 percent from its previous close.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Dish TV seeks to extend AGM, says requires regulatory nod for suggested changes on board
2Amazon expands language support for sellers ahead of festive season; teases Great Indian Festival sale
3Vodafone Idea claims to record peak 5G speed of 3.7 gbps during trials in Pune